Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes
Hicham Skali(Dana-Farber/Harvard Cancer Center), Sharmila Dorbala(Brigham and Women's Hospital), James K. Min(Cornell University), Leslee J. Shaw(Allegheny College), Brent A. Williams(Mayo Clinic), Benjamin J.W. Chow(Tufts Medical Center), Rob Beanlands(University of Ottawa), Guido Germano(Systemic Risk Centre), Michael E. Merhige, Marcelo F. Di Carli(Brigham and Women's Hospital), Emir Veledar(University of Miami), Daniel S. Berman(Cedars-Sinai Medical Center), Ron Blankstein(Brigham and Women's Hospital)
Cited by 11
Related Papers
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden
|Circulation|2008|1.6k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
|Journal of the American College of Cardiology|2012|1.6k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k